9.72
-0.32 (-3.19%)
-0.32 (-3.19%)
Upgrade to Real-Time
Afterhours (Closed)
Low
3.59
High
80.67
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Brooklyn ImmunoTherapeutics Inc | BTX | AMEX | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.32 | -3.19% | 9.72 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 9.88 | 9.41 | 10.1182 | 9.48 | 10.04 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,729 | 718,524 | $ 9.75 | $ 7,003,922 | - | 3.59 - 80.67 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 20:00:00 | 5,787 | $ 9.48 | USD |
Period:
Draw Mode:
Brooklyn ImmunoTherapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 502.81M | 51.73M | 35.91M | $ - | $ - | -0.79 | -12.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 88.44k | 12.10% |
Brooklyn ImmunoTherapeut... News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 12.45 | 12.52 | 9.25 | 10.23 | 1,237,457 | -2.73 | -21.93% |
| 1 Month | 11.00 | 13.63 | 9.25 | 11.38 | 861,635 | -1.28 | -11.64% |
| 3 Months | 17.24 | 17.25 | 8.80 | 11.82 | 1,199,414 | -7.52 | -43.62% |
| 6 Months | 4.90 | 80.67 | 3.59 | 27.80 | 5,136,414 | 4.82 | 98.37% |
| 1 Year | 4.90 | 80.67 | 3.59 | 27.80 | 5,136,414 | 4.82 | 98.37% |
| 3 Years | 2.52 | 80.67 | 0.66 | 22.93 | 2,303,888 | 7.20 | 285.71% |
| 5 Years | 3.90 | 80.67 | 0.66 | 19.01 | 1,171,717 | 5.82 | 149.23% |
Brooklyn ImmunoTherapeut... Description
| Brooklyn ImmunoTherapeutics Inc is a clinical stage biopharmaceutical company. It is developing IRX-2, a novel hd-IL-2 -based therapy, to treat patients with cancer. IRX-2 delivers hd-IL-2 and other key cytokines to potentially restore immune function in the tumor microenvironment, enabling the immune system to attack cancer cells. |
